Effect of Distress, Anxiety, and Depressive Symptoms on SARS-CoV-2 mRNA BNT162b2 Vaccine Efficacy in Cancer Patients
How to cite: RONDANINA, G.; BUTTIRON WEBBER, T.; D'ECCLESIIS, O.; MUSSO, M.; BRIATA, I. M.; PROVINCIALI, N.; BOITANO, M.; CLAVAREZZA, M.; D'AMICO, M.; DEFFERRARI, C.; GOZZA, A.; INNOCENTI, L.; CARBONE, A.; OLIVA, M.; MARCENARO, E.; FILAURO, F.; GANDINI, S.; DECENSI, A. Effect of Distress, Anxiety, and Depressive Symptoms on SARS-CoV-2 mRNA BNT162b2 Vaccine Efficacy in Cancer Patients. Preprints 2024, 2024102215. https://doi.org/10.20944/preprints202410.2215.v1 RONDANINA, G.; BUTTIRON WEBBER, T.; D'ECCLESIIS, O.; MUSSO, M.; BRIATA, I. M.; PROVINCIALI, N.; BOITANO, M.; CLAVAREZZA, M.; D'AMICO, M.; DEFFERRARI, C.; GOZZA, A.; INNOCENTI, L.; CARBONE, A.; OLIVA, M.; MARCENARO, E.; FILAURO, F.; GANDINI, S.; DECENSI, A. Effect of Distress, Anxiety, and Depressive Symptoms on SARS-CoV-2 mRNA BNT162b2 Vaccine Efficacy in Cancer Patients. Preprints 2024, 2024102215. https://doi.org/10.20944/preprints202410.2215.v1
Abstract
Keywords
Subject
Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Comments (0)
We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.
Leave a public commentSend a private comment to the author(s)